Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05139329 · ClinicalTrials.gov registry record
The ORCHESTRATE-Myocarditis Registry
A clinical trial, sponsored by Kansas City Heart Rhythm Research Foundation.
- Not yet
- Registry status
- 382
- Enrollment target
NCT05139329: Clinical Trial study, sponsored by Kansas City Heart Rhythm Research Foundation.
NCT05139329 is a clinical trial that has not yet begun recruiting, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 382 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05139329 has not yet begun recruiting, sponsored by Kansas City Heart Rhythm Research Foundation.
- NOT YET RECRUITING
- Registry status
- 382 participants
- Enrollment target
Study Summary
A retrospective, observational study consisting of patients who presents with typical/atypical chest pain and have an ensuing negative ischemic evaluation
Primary Outcome
To quantify the number of patients with unrecognized and underlying myocarditis as a presentation of typical and atypical chest pain followed by a negative ischemic workup.
Interventions
- DIAGNOSTIC_TEST Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 382 participants |
| Start Date | 2026-01 |
| Est. Completion | 2026-05 |
What is known before NCT05139329 opens enrollment
NCT05139329 is an observational study that tracks outcomes without assigning an intervention. The registered 382 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Imaging is the first listed.
NCT05139329 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05139329 about?
NCT05139329 is a clinical study titled "The ORCHESTRATE-Myocarditis Registry". A retrospective, observational study consisting of patients who presents with typical/atypical chest pain and have an ensuing negative ischemic evaluation
What is the current status of trial NCT05139329?
This trial is currently not yet recruiting. The enrollment target is 382 participants. The study started on 2026-01. Estimated completion is 2026-05.
What interventions are being tested in trial NCT05139329?
The interventions under investigation include: Imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05139329?
This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05677490 · 382 participants · Phase 3
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- NCT06196008 · 382 participants · NA
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
- NCT07100990 · 382 participants · Phase 3
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
- NCT06056830 · 383 participants · Phase 3
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia